Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Adenylyl Cyclase 5 Regulation by Gβγ Involves Isoform-Specific Use of Multiple Interaction Sites

Cameron S. Brand, Rachna Sadana, Sundeep Malik, Alan V. Smrcka and Carmen W. Dessauer
Molecular Pharmacology October 2015, 88 (4) 758-767; DOI: https://doi.org/10.1124/mol.115.099556
Cameron S. Brand
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachna Sadana
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sundeep Malik
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan V. Smrcka
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen W. Dessauer
Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, Texas (C.S.B., C.W.D.); Department of Natural Sciences, University of Houston-Downtown, Houston, Texas (R.S.); and Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, New York (S.M., A.V.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Visual Overview

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

Adenylyl cyclase (AC) converts ATP into cyclic AMP (cAMP), an important second messenger in cell signaling. Heterotrimeric G proteins and other regulators are important for control of AC activity. Depending on the AC isoform, Gβγ subunits can either conditionally stimulate or inhibit cAMP synthesis. We previously showed that the Gαs-βγ heterotrimer binds to the N terminus (NT) of type 5 AC (AC5). We now show that Gβγ binds to the NT of a wide variety of AC isoforms. We hypothesized that Gβγ/AC5 interactions involving inactive heterotrimer and Gβγ stimulation of AC5 were separable events. Mutations of the Gβγ “hotspot” show that this site is necessary for AC5 stimulation but not for interactions with the first 198 aa of AC5NT, which is a G protein scaffolding site. This contrasts with AC6, where the Gβγ hotspot is required for both interactions with AC6NT and for stimulation of AC6. Additionally, the SIGK hotspot peptide disrupts Gβγ regulation of AC isoforms 1, 2, and 6, but not AC5. Gβγ also binds the C1/C2 catalytic domains of AC5 and AC6. Finally, cellular interactions with full-length AC5 depend on multiple sites on Gβγ. This suggests an isoform-specific mechanism in which bound Gβγ at the AC5NT is ideally situated for spatiotemporal control of AC5. We propose Gβγ regulation of AC involves multiple binding events, and the role of the AC NT for mechanisms of regulation by heterotrimeric G protein subunits is isoform-specific.

Footnotes

    • Received April 17, 2015.
    • Accepted July 23, 2015.
  • This work was supported by the National Institutes of Health Institute of General Medical Sciences [Grants R01-GM60419 and R01-GM81772].

  • Portions of this work were previously presented in published abstract form: Cameron S. Brand, Rachna Sadana, Sundeep Malik, Alan V. Smrcka, and Carmen W. Dessauer (2011) Two Distinct Sites on Gβγ are Required for Binding to the N-Terminus Versus the Activation Site on Adenylyl Cyclase, in FASEB J 25:1011.7.

  • dx.doi.org/10.1124/mol.115.099556.

  • Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 88 (4)
Molecular Pharmacology
Vol. 88, Issue 4
1 Oct 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Adenylyl Cyclase 5 Regulation by Gβγ Involves Isoform-Specific Use of Multiple Interaction Sites
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Complexity of Gβγ Regulation of AC

Cameron S. Brand, Rachna Sadana, Sundeep Malik, Alan V. Smrcka and Carmen W. Dessauer
Molecular Pharmacology October 1, 2015, 88 (4) 758-767; DOI: https://doi.org/10.1124/mol.115.099556

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Complexity of Gβγ Regulation of AC

Cameron S. Brand, Rachna Sadana, Sundeep Malik, Alan V. Smrcka and Carmen W. Dessauer
Molecular Pharmacology October 1, 2015, 88 (4) 758-767; DOI: https://doi.org/10.1124/mol.115.099556
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Polypharmacology of CBL0137 in the African Trypanosome
  • Peptide-mediated differential signaling at GPR83
  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics